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Abstract
Motivation: Biological data and knowledge bases increasingly rely on Semantic Web
technologies and the use of knowledge graphs for data integration, retrieval and
federated queries. In the past years, feature learning methods that are applicable to
graph-structured data are becoming available, but have not yet widely been applied
and evaluated on structured biological knowledge.
Results: We develop a novel method for feature learning on biological knowledge
graphs. Our method combines symbolic methods, in particular knowledge
representation using symbolic logic and automated reasoning, with neural networks to
generate embeddings of nodes that encode for related information within knowledge
graphs. Through the use of symbolic logic, these embeddings contain both explicit and
implicit information. We apply these embeddings to the prediction of edges in the
knowledge graph representing problems of function prediction, finding candidate genes
of diseases, protein-protein interactions, or drug target relations, and demonstrate
performance that matches and sometimes outperforms traditional approaches based on
manually crafted features. Our method can be applied to any biological knowledge
graph, and will thereby open up the increasing amount of Semantic Web based
knowledge bases in biology to use in machine learning and data analytics.
Availability and Implementation:
https://github.com/bio-ontology-research-group/walking-rdf-and-owl
Contact: robert.hoehndorf@kaust.edu.sa
1 Introduction
The Semantic Web [Berners-Lee et al.(2001)], a project with the stated purpose of
forming a consistent logical and meaningful web of data using semantic technologies to
1/15
make data machine-understandable and processable, has been highly successful in
biology and biomedicine [Katayama et al.(2014)]. Many major bioinformatics
databases now make their data available as Linked Data in which both biological
entities and connections between them are identified through a unique identifier (an
Internationalized Resource Identifier or IRI) and the connections between them are
expressed through standardized relations [Wood et al.(2014),Smith et al.(2005)].
Linked Data can enable interoperability between multiple databases simply by reusing
identifiers and utilizing no-SQL query languages such as
SPARQL [Seaborne and Prud’hommeaux(2008)] that can perform distributed queries
over multiple databases. Some of the first major efforts to make life science data
available as Linked Data have been the UniProt RDF
initiative [The UniProt Consortium(2015)] and the Bio2RDF
project [Belleau et al.(2008),Callahan et al.(2013)]. UniProt focuses on making data
within a single database, UniProt, available as Linked Data so that information and
identifiers can be reused in other databases, while Bio2RDF has the aim to combine
multiple databases and demonstrate the potential of Linked Data in life sciences, in
particular with regard to provenance tracking, usability and interoperability. Now,
major databases, such as those provided by the European Bioinformatics Institute
(EBI) and the National Center for Biotechnology Information (NCBI), are made
available as Linked Data [Jupp et al.(2014),Kim et al.(2016)]. Additionally,
community guidelines and principles for data publishing such as the FAIR
principles [Wilkinson et al.(2016)] require data to be made available in a way that is
amenable to interoperability through linking and federation of queries.
A second major component of applications of the Semantic Web in the life sciences
has been the development and use of ontologies. Ontologies are specificiations of a
conceptualization of a domain [Gruber(1995)], i.e., they formally and explicitly specify
some of the main regularities (classes of entities) that can be found within a domain
and their interconnections [Hoehndorf et al.(2015a)]. Ontologies are now widely used
in biological datasets for the annotation and provision of metadata. They are
commonly represented in formal languages with model theoretic
semantics [Grau et al.(2008),Horrocks(2007)] which makes them amenable to
automated reasoning. However, the large size of the ontologies and the complexity of
the languages and reasoning tasks involved have somewhat limited ontologies’ use in
automated reasoning. In particular, there is still a large disparity between the
ontologies in biomedicine and the databases that uses them for annotation. While
inferences over the ontologies, as part of ontology development and quality assurance
process, become increasingly
common [Mungall et al.(2012),The Gene Ontology Consortium(2015)], they are not
always applied to infer new relations between biomedical data.
Recently, several machine learning methods have become available that can be
utilized to learn features from raw data [Lecun et al.(2015)]. Several of these methods
can also be applied to graph-structured
data [Yanardag and Vishwanathan(2015),Perozzi et al.(2014)]. While most of these
methods are developed for graphs without edge labels (in contrast to Linked Data in
which edge labels represent the type of relation between entities), some methods have
also been extended to incorporate edge labels [Ristoski and Paulheim(2016)]. However,
to be applicable to biological data, a crucial aspect is the interoperability between
both the data layer (as expressed in Linked Data formats) and the annotations of data
items or semantic layer (expressed through ontologies and the background knowledge
they provide). This tight integration between data and knowledge, as dominantly
present in biological databases, benefits from automated reasoning so that it becomes
possible to consider inferred knowledge, handle data consistency and identify
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incompatible conceptualizations.
We developed a method to leverage the semantic layer in knowledge graphs such as
the Semantic Web or Wikidata by combining automated reasoning over ontologies and
feature learning with neural networks, to generate vector representations of nodes in
these graphs (node embeddings). We demonstrate that these representations can be
used to predict edges with biological meaning. In particular, we demonstrate that our
approach can predict disease genes, drug targets, drug indications, gene functions and
other associations with high accuracy, in many cases matching or outperforming state
of the art methods.
Our results demonstrate how Linked Data and ontologies can be used to form
biological knowledge graphs in which heterogeneous biological data and knowledge are
combined within a formal framework, and that these graphs can not only be used for
data retrieval and search, but provide a powerful means for data analysis and
discovery of novel biological knowledge.
2 Methods
2.1 Data Description
In our experiments, we build a knowledge graph based on three ontologies: the Gene
Ontology (GO) [Ashburner et al.(2000)] downloaded on 18 July 2016, the Human
Phenotype Ontology [Ko¨hler et al.(2014)] downloaded on 18 July 2016, and the
Disease Ontology [Kibbe et al.(2014)] downloaded on 19 August 2016. We also use the
following biological databases in our knowledge graph:
• Human GO annotations from SwissProt [The UniProt Consortium(2015)], and
phenotype annotations from the HPO databases [Ko¨hler et al.(2014)],
downloaded on 23 July 2016. We include a total of 211,975 GO annotations and
153,575 phenotype annotations.
• Human Proteins interactions from the STRING
database [Szklarczyk et al.(2011)] downloaded on 18 July 2016. We filter
proteins by their interactions confidence score and choose those above 700. The
total number of interactions in this dataset is 188,424.
• Human chemical–protein interactions downloaded from the STITCH
database [Kuhn et al.(2012)], on 28 August 2016, filtered for confidence score of
700. The total number of drug-target interactions present in the graph is
554,366.
• Genes and disease associations from DisGeNET [Pin˜ero et al.(2015)],
downloaded on 28 August 2016, consisting of 236,259 associations.
• Drug side effects and indications from SIDER [Kuhn et al.(2010)], downloaded
on 15 August 2016. We include a total of 48,702 drug–side effect pairs and 6,159
drug–indication pairs in our graph.
• Diseases and their phenotypes from the HPO database [Ko¨hler et al.(2014)] and
text mining [Hoehndorf et al.(2015b)]. We include a total of 84,508 phenotype
annotations of diseases.
We map all protein identifiers to Entrez gene identifiers and use these to represent
both genes and proteins. We use PubChem identifiers to represent chemicals and we
map UMLS identifiers associated with diseases in DisGeNET and indications in
SIDER to the Disease Ontology using mappings provided by Disease Ontology. We
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further map UMLS identifiers associated with side effects in SIDER to HPO identifiers
using mapping between UMLS and HPO [Hoehndorf et al.(2014)].
A knowledge graph is a graph-based representation of entities in the world and
their interrelations. Knowledge graphs are widely used to facilitate and improve
search, and they are increasingly being developed and used through Semantic Web
technologies such as the Resource Description Framework
(RDF) [Candan et al.(2001)]. Here, we focus on knowledge graphs centered around
biological entities and their interactions, ignoring all meta-data including labels or
provenance. The knowledge graphs we consider have two distinct types of entities:
biological entities, and classes from biomedical ontologies that provide background
knowledge about a domain. The aim of building a biological knowledge graph is to
represent, within a single formal structure, biological relations between entities, their
annotations with biological ontologies, and the background knowledge in ontologies.
We make a clear distinction beween instances and classes. While there is some
debate about which kinds of biological entities should be treated as instances and
which as classes [Smith et al.(2005)], similarly to other Linked Data
approaches [The UniProt Consortium(2015)], we treat biological entities such as types
of proteins, diseases, or chemicals, as instances in the knowledge graph. In our case,
classes from the Disease Ontology are also treated as instances. On the level of
instances, we can integrate existing graph-based representations used in biology and
biomedicine, in particular biological networks such as protein-protein interaction
networks, genetic interaction networks, metabolic interactions or pathways.
Ontology-based annotations are expressed by asserting a relation between the
instance (e.g., a disease or protein) and an instance of the ontology class. For example,
we express the information that the protein Foxp2 has the function transcription
factor binding (GO:0003700) by the two axioms hasFunction(foxp2, f1) and
instanceOf(f1, GO : 0003700) where foxp2 and f1 are instances, GO : 0003700 the
class http://purl.obolibrary.org/obo/GO 0003700 in GO, hasFunction an object
property, and instanceOf the rdf:type property specified in the OWL
standard [OWL Working Group(27 October 2009)] as expressing an instantiation
relation. The instance f1 can be expressed as an anonymous instance (i.e., a blank
node in the RDF representation) or be assigned a unique new IRI. In our knowledge
graph, we create a new IRI (i.e., an IRI that does not occur anywhere else in the
graph) for each of these instances.
2.2 Ontology-based classification
Due to the large size of the knowledge graphs we process, we rely on polynomial-time
automated reasoning methods. OWL provides three profiles [Motik et al.(2009)] that
facilitate polynomial time inferences, and multiple RDF stores implement different
subsets of OWL to facilitate inferences and improve querying. For example, the
OWL-Horst subset [ter Horst(2005)] is used by several RDF stores and is useful in
data management and querying. In biological and biomedical ontologies, the OWL 2
EL profile is widely used to develop the large ontologies that are in use in the domain,
and has been found to be useful and sufficient for a large number of
tasks [Hoehndorf et al.(2011),Mungall et al.(2012),Suntisrivaraporn et al.(2007)].
OWL 2 EL supports basic inferences over ontologies’ class hierarchies (including
intersection, existential quantification and disjointness between named classes),
supports inferences over object properties (transitivity, reflexivity, and object property
composition), and can infer the classification of instances. We make use of OWL 2 EL
for representing the knowledge graphs we generate and utilize the ELK
reasoner [Kazakov et al.(2014)] for automated reasoning over them. In principle, other
profiles of OWL can also be used following a similar approach, but may not be feasible
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due to the high computational complexity of generating
inferences [Baader et al.(2003)]. OWL 2 EL supports the following class descriptions,
class and object property axioms (using capital letters for classes, lower case letters for
object properties, and x1, x2, ... for instances):
• Class description: class intersection (A ⊓B), existential quantification (∃r.A),
limited enumeration using a single instance ({x1})
• Class axioms: subclass (A ⊑ B), equivalent class (A ≡ B), disjointness (
A ⊓B ⊑ ⊥)
• Object property axioms: sub-property (r ⊑ s), property chains ( r ◦ s ⊑ q),
equivalent property ( r ≡ s), transitive properties (r ◦ r ⊑ r), reflexive properties
We deductively close the knowledge graph with respect to the OWL 2 EL profile,
using an OWL 2 EL reasoner [Kazakov et al.(2014)]. A knowledge graph KG is
deductively closed if and only if for all φ such that KG |= φ, φ ∈ KG. In general, the
deductive closure of a knowledge is countably infinite. Therefore, we only add
inferences that can be represented explicitly as edges between named individuals and
classes in KG, i.e., between entities that are explicitly named in KG. In particular, for
all instances xi, xj ∈ KG and object properties (i.e., edge labels) r ∈ KG, if
KG |= r(xi, xj), then r(xi, xj) ∈ KG
|=. Furthermore, for all named classes C ∈ KG and
instances x ∈ KG, if KG |= C(x), then C(x) ∈ KG|=. Finally, we also infer relations
between classes, in particular subclass axioms, and add them to the inferred graph: for
any class C,D ∈ KG, if KG |= C ⊑ D, then C ⊑ D ∈ KG|=.
We use the OWL API version 4 [Horridge et al.(2007)] to classify the input
knowledge graph and add all inferences obtained by using the ELK reasoner as new
edges to the knowledge graph to generate KG|=. We use this fully inferred graph as a
basis for generating the node embeddings through our method.
2.3 Walking RDF and OWL
To generate node embeddings, we use a modified version of the DeepWalk
algorithm [Perozzi et al.(2014)] in which we consider edge labels as part of the walk. A
random walk of length n over a graph G = (V,E) and start vertex v0 ∈ V is an
ordered sequence of vertices (v0, ..., vn), vi ∈ V , and each vi (i > 0) is determined by
randomly selecting an adjacent node of vi−1. As knowledge graphs generated by our
method additionally have edges of different types (i.e., edge labels, L(E)), we extend
this notion to edge-labeled random walks. An edge-labeled random walk of length n
over the graph G = (V,E), edge labels L : E 7→ L in the label space L (i.e., the set of
object properties in the knowledge graph underlying G), and start vertex v0 ∈ V is a
sequence (v0, l1, v1, ..., ln, vn) such that vi ∈ V , li ∈ L, and, starting with v0 and for all
vi (i < n), a random outgoing edge ei+1 of vi, ending in vi+1 is chosen to generate li+1
from L(ei+1) and vi+1.
We implement this algorithm as an extension of the
DeepWalk [Perozzi et al.(2014)]. The algorithm takes a knowledge graph G = (V,E)
as input and generates a corpus C consisting of a set of edge-labeled random walks,
starting either from all vertices v ∈ V , or all vertices v ∈ U of a specified subset of
U ⊆ V . Parameters of the algorithm are the length of the walks and the number of
walks per node. Source code of the algorithm and documentation are freely available
at https://github.com/bio-ontology-research-group/walking-rdf-and-owl.
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2.4 Learning Embeddings
We use the corpus C of edge-labeled random walks as an input for learning
embeddings of each node. We follow the skip-gram model [Mikolov et al.(2013)] to
generate these embeddings. Given a sequence of words, (w1, ..., wN ) in C, a skip-gram
model aims to maximize the average log probability
1
N
N∑
n=1
∑
−c≤j≤c,j 6=0
log p(wn+j |wn) (1)
in which c represents a context or window size. To define p(wn+j |wn), we use negative
sampling, following [Mikolov et al.(2013)], i.e., replacing log p(wO|wI) above with a
function to discriminate target words (wO) from a noise distribution
Pn(w) [Mikolov et al.(2013)], drawing k words from Pn(w):
log σ(v
′
⊺
wO
vwI ) +
k∑
i=1
Ewi∼Pn(w)
[
log σ(−v
′
⊺
wi
vwI )
]
(2)
The vector representation (embedding) of a word s occurring in corpus C is the vector
vs in Eqn. 2 derived by maximizing Eqn. 1. The dimension of this vector is a
parameter of the method.
Since our corpus consists of often repeated edge labels (due to the relatively small
size of the label space L), we further use sub-sampling of frequent
words [Mikolov et al.(2013)] (which mainly represent edge labels in the corpora we
generate) to improve the quality of node embeddings. We follow [Mikolov et al.(2013)]
and discard, during training, each word wi (i.e., node or edge) with a probability
P (wi) = 1−
√
t
f(wi)
where t is a threshold parameter.
It is obvious from this formulation that the parameters for learning the
representation of nodes in a knowledge graph include the number of walks to perform
for each vertex, the length of each individual walk, a subset U of vertices from which
to start walks, the size of the vector representations learned by the skip-gram model,
the window or context size employed in the skip-gram model, the parameter t used to
sub-sample frequent words (we use t = 10−3 for all our experiments), and the number
of words to draw from the noise distribution (we fix this parameter to 5 in our
experiments). There are several additional parameters for training a skip-gram model,
including learning rate and certain processing steps on the corpus, for which we chose
default values in the gensim (https://radimrehurek.com/gensim/) skip-gram
implementation.
2.5 Prediction
The embeddings can be used as features in machine learning tasks that should encode
for the local neighborhood of each node, thereby encoding for the (local) information
contained in a knowledge graph about a certain vertex. We apply these features to the
task of edge prediction, in which we aim to estimate the probability that an edge with
label l exists between vertices v1 and v2 given their vector representation, v(v1) and
v(v2): p((v1, v2, l) ∈ E|〈v(v1), v(v2)〉). We use the logistic regression classifier
implemented in the sklearn library [Pedregosa et al.(2011)] to train logistic regression
models.
We build separate binary prediction models for each edge type in the knowledge
graphs. For model building and testing, we employ 5-fold cross-validation. Each
cross-validation fold is built by randomly removing 20% of edges of a particular type
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in the knowledge graph, then applying deductive inference, corpus generation through
edge-labeled random walks, learning of vector representations of nodes, and building
of a binary logistic regression model. A model for edges with label l is trained using as
positive instances all pairs of vertices for which an edge with label l exists in the
modified knowledge graph (in which 20% of edges with label l have previously been
removed), and using as negatives a random subset of all pairs of vertices (vr1 , vr2) such
that vr1 is of the same type (i.e., an instance of the same class in the knowledge graph)
as all sources of edges with label l, and vr2 is of the same type as all targets of edges
with label l. For example, if edges with label l are all between instances of Drug and
Disease in a knowledge graph, then we sub-sample negative instances among all pairs
of instances of Drug and Disease for which no edge exists in the original knowledge
graph. The constraint of choosing negatives from the same general types of entities is
necessary because instances of different types will be clearly separable within the
embeddings, and evaluation using those would therefore bias the results. We randomly
generate a set of negative samples with the same cardinality as the set of positive
samples, both for model training and prediction.
The embeddings can also be used for findings similar nodes using a measure of
similarity. We use cosine similarity to compute the similarity between two vectors:
sim(v1, v2) =
v1·v2
‖A‖‖B‖
2.6 Parameter optimization
Using the performance on the final prediction model, we perform parameter
optimization through a limited grid search. We only optimize embedding size, number
of walks, walk length and context size for the skip-gram model through a grid search
since an exhaustive optimization would be too computationally expensive.
Furthermore, we only use a single edge type to test how results change with each
choice of parameter, due to computational constraints. We tested the following 625
parameters : embedding sizes of 32, 64, 128, 256, and 512, number of walks 50, 100,
200, 300, and 500, walk length 5, 10, 15, 20, and 30, and skip-gram context sizes 5, 10,
15, 20, and 30. We found the best performing parameters to be 512 for the embedding
size, 100 for the number of walks, 20 for the walks length and 10 for the skip-gram
context size, and we fix these parameters throughout our experiments.
3 Results
3.1 Neuro-symbolic feature learning using Semantic Web
technologies
We build a knowledge graph using Semantic Web technologies centered on human
biomedical data. The graph incorporates several biological and biomedical datasets
and is split in two layers, instances and classes. On the level of instances in the
knowledge graph, we combine protein-protein interactions
(PPIs) [Szklarczyk et al.(2011)], chemicals (drugs) and their protein
targets [Kuhn et al.(2012)], drugs and their indications [Kuhn et al.(2010)], and genes
and the diseases they are involved in [Pin˜ero et al.(2015)]. On the level of classes, we
include the Human Phenotype Ontology [Ko¨hler et al.(2014)], and the Gene
Ontology [Ashburner et al.(2000)], and we include annotations of diseases and their
phenotypes [Ko¨hler et al.(2014),Hoehndorf et al.(2015b)], genes and their
phenotypes [Ko¨hler et al.(2014)], and human protein functions and subcellular
locations [The UniProt Consortium(2015)]. The knowledge graph, including the data,
ontologies and our formal representation of ontology-based annotations, consists of
7/15
7,855,737 triples. We use the Elk reasoner [Kazakov et al.(2014)] to deductively close
this graph, and through the application of ontology-based inference, we further infer
5,664,387 new triples and add them to the knowledge graph.
We utilize this knowledge graph as the input to our algorithm that can learn
representations of nodes. These representations represent the neighborhood of a node
as well as the kind of relations that exist to the neighboring nodes. To learn these
representations, we perform random walks from each node in the knowledge graph
repeatedly, use the resulting walks as sentences within a corpus, and apply the
Word2Vec skip-gram model [Mikolov et al.(2013)] to learn embeddings for each node.
We use the fully inferred, deductively closed knowledge graph to perform the
random walks. Performing random walks on the deductively closed graph has the
advantage that not only asserted axioms will be taken into consideration, but
representations can also include inferred knowledge that is not present explicitly in the
graph. For example, for an assertion that a gene g has a function F (where F is a
class in the GO), all superclasses of F in GO will be added as annotations to g;
sub-properties (such as binds ⊆ interacts-with) asserted in an ontology or database
will be resolved; transitive, reflexive object properties and property chains resolved
and the inferred edges added.
We automated these steps (ontology-based classification, repeated random walk,
generation of embeddings) in an algorithm that combines the steps relying on
symbolic inference and the learning of embeddings using a neural network. The input
of the algorithm is a knowledge graph and the parameters needed for the algorithm
such as the length and number of walks and size of the resulting embeddings, the
output is an embedding (of a specified size) for each node in the knowledge graph.
Figure 1 illustrates our basic workflow.
Figure 1. Overview over the main steps in our workflow. We first build biologi-
cal knowledge graphs by integrating Linked Data, biomedical ontologies, and ontology-
based annotations in a single, two-layered graph, then deductively close the graph using
automated reasoning and apply feature learning on the inferred graph to take into ac-
count both explicitly represented data and inferred information.
3.2 Edge Prediction
The resulting embeddings can be used in standard machine learning classifiers. We
demonstrate these uses in two settings. First, we remove edges from the knowledge
graph, regenerate the embeddings using the reduced graph, and train a logistic
regression classifier to predict whether or not an edge exists between two nodes, given
the embeddings for two nodes as input. This kind of application is intended to
demonstrate how associations between two potentially different types of entities, such
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as a gene and disease, can be identified. We perform these experiments in 5-fold
cross-validation setting for every edge type in our graph except edges that exist only
between ontology classes. Table 1 summarizes the results.
Table 1. Performance results for edge prediction in a biological knowledge graph. Edge
types marked with an asterix are between instances and instances of ontology classes.
Edge Type
Without reasoning With reasoning
F-measure AUC F-measure AUC
has target 0.94 0.97 0.94 0.98
has disease annotation 0.89 0.95 0.89 0.95
has side-effect∗ 0.86 0.93 0.87 0.94
has interaction 0.82 0.88 0.82 0.88
has function∗ 0.85 0.95 0.83 0.91
has gene phenotype∗ 0.84 0.91 0.82 0.90
has indication 0.72 0.79 0.76 0.83
has disease phenotype∗ 0.72 0.78 0.70 0.77
We find that the performance of the prediction differs significantly by edge type,
but some types of relations can be predicted with high F-measure. Furthermore, using
the knowledge graph with reasoning improves the performance slightly when
predicting edges between instances and mostly results in decreased performance when
aiming to predict edges between instances and and instance of an ontology class. We
achieve overall highest performance on predicting has target edges with an F-measure
of 0.94 and ROCAUC of 0.98, and lowest overall performance on associations between
diseases and their phenotypes (has disease phenotype, ROCAUC 0.77). While our aim
here is not to propose a novel method of predicting drug targets, protein functions or
phenotypes, state of the art approaches that incorporate multiple types of information
and use graph inference for predicting drug–target edges achieve ROCAUC of up to
0.93 [Wang et al.(2013),Wang et al.(2014)], albeit using a different set of positive and
negative drug–target pairs. Similarly, some of the edges, such as has function or has
phenotype, have to be predicted in a hierarchical output space (i.e., an ontology such
as the Gene Ontology [Ashburner et al.(2000)] and the Human Phenotype
Ontology [Ko¨hler et al.(2014)]) and need to satisfy additional consistency constraints
(due to formal dependencies between the labels), which may overall result in lower
performance when applied to these tasks [Radivojac et al.(2013),Sokolov et al.(2013)].
While the evaluation results demonstrate that the embeddings of vertices learned
through our approach contain sufficient information about the node to be useful in
predictive models, more specific knowledge graphs, containing different types of
information, need to be built for specific applications.
3.3 Drug repurposing on biological knowledge graphs
As second use case, we also test how well the node embeddings can be used to predict
novel relations, i.e., relations that are not explicitly represented in the knowledge
graph. Such an evaluation can provide information about how well the embeddings
our algorithm generates can be reused in novel applications or as part of larger
predictive systems for hypothesis generation [Gottlieb et al.(2011)].
We aim to test how much information about shared mode of action is encoded in
the embeddings of drug nodes generated by our method, and how the performance of
our approach compares to related efforts. Using side-effect similarity alone, it is
possible to identify pairs of drugs that share protein targets and
indications [Campillos et al.(2008),Tatonetti et al.(2012)], thereby demonstrating that
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side effects provide some information about drugs’ modes of
action [Campillos et al.(2008)]. We train a logistic regression classifier to predict
whether a pair of drugs (represented by the embeddings we generate) share an
indication or target. To make our input data comparable to studies that compare only
drugs’ side effects, and to avoid bias introduced by encoding targets and indications in
the knowledge graph, we remove all has indication and has target edges from our
graph and further retain only drugs contained in the SIDER
database [Kuhn et al.(2010)]. We then train a logistic regression classifier to
determine whether a pair of drugs shares an indication, a target, or both, using 80% of
the drug pairs as training and keeping 20% as testing.
Figure 2 shows the resulting performance. We can achieve up to 0.87 ROCAUC for
predicting pairs of drugs that share both an indication and a target, 0.79 ROCAUC
for drugs that share targets, and 0.77 ROCAUC for drugs that share indications. In
comparison, ranking drug pairs by their side effect similarity alone can achieve a
ROCAUC of up to 0.75 for drugs sharing targets and 0.83 for drugs sharing
indications [Tatonetti et al.(2012)]. Our results demonstrate that our method
generates embeddings that encode for the explicit information in a knowledge graph, is
capable of utilizing this for prediction and achieve comparable results to other
approaches. Moreover, after removing has target and has indication edges, drugs are
not directly linked to protein-protein interactions, protein functions or disease
phenotypes. Nevertheless, the embeddings generated for drugs based on the corpus
generated by random walks can encode some of this information, for example by
linking both genes and drugs to similar phenotypes (and thereby providing
information about potential drug targets), linking diseases and drugs to similar
phenotypes (and thereby providing information about potential indications), as well as
more complex interactions.
Instead of using a classifier, similarity between the embeddings can also be
exploited to identify biological relations. Using the full knowledge graph, we further
tested whether drug-drug similarity can be used to identify drugs that fall in the same
indication group. We use cosine similarity to determine how similar two drugs are and
evaluate whether drugs that share the same top-level Anatomical Therapeutic
Chemical Classification System (ATC) code are more similar than drugs that do not
share codes. We find drugs in the same ATC top-level category are significantly
(p < 3 · 10−4 , Mann-Whitney U test) more similar than drugs that do not fall in the
same ATC top-level category.
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Figure 2. ROCAUC test scores of SIDER drug pairs the for predicting novel indications
or targets or both.
10/15
4 Discussion
A limitation of our approach is the reliance on qualitative data and ignoring
quantitative information. Many of the edges in biological networks have associated
weights that represent either the strength of a biological relation or the certainty of
the existence of a relation. For example, networks which are based primarily on
correlation between quantitative, experimentally measured variables use correlation
coefficients to quantify the strength of a biological association, while network
databases such as STRING [Szklarczyk et al.(2011)] include data from multiple
databases and associate a confidence value for the existence of an edge. While random
walk algorithms can, in principle, be extended to account for edge
weights [Coppersmith et al.(1993)], the different semantics of the edge weights will
require different treatments by the algorithm. In particular, incorporating edge
weights may need to distinguish between weights that represent confidence in the
existence of a relation (as in confidence scores from a prediction method) and weights
that quantify the biological strength of the relation (as in correlation coefficients).
Despite the large success of machine learning methods in the past
years [Lecun et al.(2015)], they have not yet widely been applied to symbolically
represented biological knowledge. Symbolic representations in biology, based on Linked
Data and ontologies, are relying on formal languages such as OWL and RDF, and
utilize symbolic inference. The kind of inferences performed on this knowledge is either
formally specified in the knowledge representation language [Baader et al.(2003)] or
arised from hand-crafted inference rules that are applicable within a particular
database, application, or query [Callahan et al.(2013),The UniProt Consortium(2015)].
Here, we use knowledge graphs built using the semantics of OWL and data is
represented as instances of OWL classes, but our approach of building knowledge
graphs can be replaced with, or amended by, the use of explicit inference rules. In this
case, instead of applying an OWL reasoner to infer edges with respect to the OWL
semantics, rules can be used to infer edges and deductively close the knowledge graph
with respect to a set of inference rules.
A key difference between the knowledge graphs we use in our approach and
knowledge graphs widely used in biological databases is the strong focus on
representing biological entities and their relations in contrast to representing the
(non-biological) meta-data about these entities and their associations, such as
provenance [Belhajjame et al.(2012)] and authorship. While inclusion of such
metadata in knowledge graphs is required for retrieval and to ensure data
quality [Wilkinson et al.(2016)], our method relies on the use of data models that make
it possible to separate the biological content of a knowledge graph from the metadata.
We demonstrate that knowledge graphs based on Semantic Web standards and
technologies can not only be used to store and query biological information, but also
have the capability to model and represent biological phenomena, such as the totality
of known protein-protein interactions within a cell. The key advantage of choosing
knowledge graphs over other representations is the inherent focus on representing
heterogeneous information in contrast to single types of relations, the possibility to
continuously add information, the use of inference rules, and the use of World Wide
Web standards. Our method allows all these advantages to be utilized for data
analysis and to build predictive models, and may encourage database curators and
biologists to increasingly rely on knowledge graphs to represent the biological
phenomena of their interest.
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